Clean Yield Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Clean Yield Group’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-8	Closed	-$7.03K	–	394
2023 Q4	$7.03K	Hold	8	–	–	﹤0.01%	325
2023 Q3	$6.69K	Hold	8	–	–	﹤0.01%	333
2023 Q2	$5.75K	Hold	8	–	–	﹤0.01%	348
2023 Q1	$6.57K	Hold	8	–	–	﹤0.01%	350
2022 Q4	$5.77K	Hold	8	–	–	﹤0.01%	367
2022 Q3	$6K	Hold	8	–	–	﹤0.01%	351
2022 Q2	$5K	Hold	8	–	–	﹤0.01%	379
2022 Q1	$6K	Hold	8	–	–	﹤0.01%	393
2021 Q4	$5K	Hold	8	–	–	﹤0.01%	411
2021 Q3	$5K	Buy	+8	New	+$4.97K	﹤0.01%	430
2019 Q4	–	Sell	-25	Closed	-$7K	–	361
2019 Q3	$7K	Buy	+25	New	+$7.4K	﹤0.01%	309
2019 Q2	–	Sell	-5	Closed	-$2K	–	356
2019 Q1	$2K	Buy	+5	New	+$2.06K	﹤0.01%	305

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Clean Yield Group's REGN Position: Q1 2024 in Review

Clean Yield Group sold out of Regeneron Pharmaceuticals (REGN) in Q1 2024, closing a stake of 8 shares — an estimated $7.03K sold.

Clean Yield Group first reported a position in REGN in Q1 2019 and held it in 12 quarters. The position peaked at $7.03K in Q4 2023. 1,312 funds tracked by Wall St. Rank hold REGN as of Q1 2024.

Clean Yield Group reported no remaining Regeneron Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
Clean Yield Group sold 8 Regeneron Pharmaceuticals shares in Q1 2024, an estimated $7.03K.
Clean Yield Group first reported a position in Regeneron Pharmaceuticals in Q1 2019 and held it in 12 quarters.
Clean Yield Group's Regeneron Pharmaceuticals position peaked at $7.03K in Q4 2023.
1,312 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2024.

Based on Clean Yield Group's 13F filing for Q1 2024, filed 29 May 2024.